„”
Dr.
Axonal tau reduction ameliorates tau and amyloid pathology in a mouse model of Alzheimer’s disease
Translational Neurodegeneration 2025
read onlineNeuropathic Pain and Distinct CASPR2 Autoantibody IgG Subclasses Drive Neuronal Hyperexcitability
Neurology Neuroimmunology & Neuroinflammation 2025
read onlinehnRNP R regulates mitochondrial movement and membrane potential in axons of motoneurons.
Neurobiology of disease 2024
read onlinehnRNP R promotes O-GlcNAcylation of eIF4G and facilitates axonal protein synthesis
Nature Communications 2024
read onlinePlekhg5 controls the unconventional secretion of Sod1 by presynaptic secretory autophagy
Nature Communications 2024
read onlineThe Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) is part of the Forschungsverbund Berlin e.V. (FVB), which legally represents seven non-university research institutes - members of the Leibniz Association - in Berlin.
Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP)
Rudower Chaussee 17
12489 Berlin, Germany